Innophos Holdings Inc has agreed to acquire Novel Ingredients, a portfolio company of GenNx360 Capital Partners, for $125 million. Lazard is serving as financial adviser to Innophos on the transaction. Headquartered in Cranbury, New Jersey, Innophos is a producer of specialty ingredient solutions.
Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps
6 November 2026 · 1 min read
Truelink Capital’s GES buys CSG Creative from National Trade Productions
6 November 2026 · 2 mins read
MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech
6 November 2026 · 2 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
6 November 2026 · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
6 November 2026 · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
6 November 2026 · 1 min read
PE targets identity security as AI transforms threats: 6 deals
6 November 2026 · 3 mins read
